U.S. Biopharmaceutical Market

U.S. Biopharmaceutical Market

U.S. Biopharmaceutical Market

Original Source: Biopharmaceutical Market

The U.S. biopharmaceuticals market is expected to increase to $144 billion by 2016. The growth is expected as a result of the launch of new products, approval of new indications for existing therapies and drugs, and increase in population aged 65 years and above. From 2009 to 2016 the U.S. market revenues are forecasted to grow at a compound annual growth rate (CAGR) of 11.2%

This research report analyzes the U.S. biopharmaceuticals market and its growth factors, with special emphasis on the top companies in the field and their product pipeline. While it looks at the overall market size and presents forecast till 2016, a key focus of the report is the increasing role of biopharmaceutical products. The growing interest in biotechnology development has led to the metamorphosis of the pharmaceutical industry, resulting in the subset industry of biopharmaceuticals. The big players in the pharma industry, including Pfizer, Merck, and Novartis, have been the first few to reap the benefits of investing in biotechnology through both organic as well as inorganic growth mechanisms.

Market forecasts include the biopharmaceuticals currently in the market as well as those projected to enter the market by the end of the forecast period in 2016. Market challenges, drivers, and restraints have also been identified and assessed. Selected late stage pipeline analysis is also included.

This report analyzes the biopharmaceutical industry's products, features, companies, market size and potential, and patent portfolios. The impact of the Medicare and Medicaid policies and individual plan behaviors on the biopharmaceutical industry is also discussed.

Scope of the report

Market Overview

This section discusses the market definition of U.S. biopharmaceutical market. This section also discusses the way market is segmented and the methodology as well as the assumptions considered for forecasting the revenues for the all the individual product/drug class segments.

Market segmentation

This research service covers biopharmaceuticals and their impact on the U.S. healthcare market.

Products included in this study by their market segmentation:

Gene and Cell therapies, including "Antisense Therapies"

Cytokines

PEH: Proteins, Enzymes, and Hormones

Monoclonal Antibodies

Vaccines

Others: Blood and Allergenic components and others.

Products not included:

Biosurgical products like tissue grafts and sealants

Biologics used for diagnostic purposes

Bionanotechnology drugs

Analysis Insights

This section discusses the current trends and focus of the U.S. biopharmaceutical market and the challenges faced by the industry. Other sections include market analysis, patent analysis and competitive landscape.

Company Profiles

This section provides the company profiles of major companies participating in the U.S. biopharmaceutical market. Company profiles include a brief overview of the company, primary business, strategies followed and developments.

What makes our report unique?

A strong heritage of providing cutting-edge research:

MarketsandMarkets provides clients with ground breaking marketing research. M&M's unique research methodology and expert analytical capabilities will provide you the tools to apply the best marketing practices to your Financial Institution.

Ensure that your strategy is viable:

Our study will help you examine the breadth of possibilities you may encounter when planning future strategies and product launches. It will help you create plans that are resilient enough to meet the full range of unanticipated events.

Discover new opportunities:

This market research study will forecast the future roles, uses, and acceptances of new products, services, and applications emerging in the marketplace. It will identify opportunities where companies can get a leg up on the competition.

Key questions answered

What are the product and application trends for digestive prebiotics, digestive probiotics and digestive enzymes?

What are the factors, which will drive the U.S. digestive health ingredients market and its various sub-segments?

What factors are inhibiting U.S. digestive health ingredients market and its various sub-segments?

What are the trends and forecasts of the U.S. digestive health ingredients market and its sub-segments?

How the competitive outlook and who are the major players in each of the segments.

Powerful Research and analysis

The analysts working with MarketsandMarkets come from renowned publishers and market research firms globally, adding their expertise and domain understanding. We get the facts from over 22,000 news and information sources, a huge database of key industry participants and draw on our relationships with more than 900 market research companies.

POST COMMENT

Discover How You Could Improve Your Earnings Via Article Marketing The highly competitive pharmaceutical companies to explore the domestic market the way overseas acquisitions - and competition - the pharmaceutical Flame Retardant Market Laws And Regulations To Be Sound And Great Potential - Flame Retardant Chemical Class Of Marketing Performance (20,090,928) - Chemical Products, Liao Tung Chemical - Six Tips For Successful Affiliates Marketing - TOP Article Submissions Article Marketing Tips The Amount Of Money You Make Online Depends On Your Self Image Email Marketing Strategy Tips Copy Paste Traffic Review - Is It A Scam? Property Investment Advice - Buyers Market Now Diamond Market Demand Prospects - Tools, Diamond, Metal Tools - Metal Industry - Fine-brick Texture Bad Forex Robots Only Lose Money: How to Make a Profit in Forex Achievements Of The Four Genes Pharmaceutical Companies, "wolf Marketing" - Marketing - Why Modern Affiliate Technology Makes Becoming a Successful Affiliate in Affiliate Marketing Much Easier